Airain Ltd’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$235K Buy
+2,324
New +$251K 0.01% 711
2016
Q1
Sell
-3,695
Closed -$402K 821
2015
Q4
$402K Buy
+3,695
New +$423K 0.03% 516
2014
Q4
Sell
-3,152
Closed -$461K 727
2014
Q3
$461K Buy
+3,152
New +$487K 0.03% 469
2014
Q1
Sell
-2,815
Closed -$538K 727
2013
Q4
$538K Buy
+2,815
New +$524K 0.07% 287

Other funds holding CLB

Airain Ltd's CLB Position: Q2 2017 in Review

Airain Ltd opened a new position in Core Laboratories (CLB) in Q2 2017: 2,324 shares worth $235K. The stake represents 0.01% of the portfolio and ranks #711 among its holdings. This is a return to the name: Airain Ltd previously reported a position in CLB as recently as Q4 2015.

Airain Ltd first reported a position in CLB in Q4 2013 and has held it in 4 quarters since. The position peaked at $538K in Q4 2013. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.

  • Airain Ltd held 2,324 shares of Core Laboratories worth $235K as of Q2 2017.
  • Core Laboratories was a new Airain Ltd position in Q2 2017.
  • Core Laboratories made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #711 holding.
  • Airain Ltd first reported a position in Core Laboratories in Q4 2013 and has held it in 4 quarters since.
  • Airain Ltd's Core Laboratories position peaked at $538K in Q4 2013.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.